259 related articles for article (PubMed ID: 34107858)
1. Traditional Chinese Medicine Decoctions Significantly Reduce the Mortality in Severe and Critically Ill Patients with COVID-19: A Retrospective Cohort Study.
Sun QG; An XD; Xie P; Jiang B; Tian JX; Yang Q; Li XY; Luo M; Liu P; Zhao SH; Duan LY; Lang SP; Fan A; Luo PC; Lian FM; Huang XD; Tong XL
Am J Chin Med; 2021; 49(5):1063-1092. PubMed ID: 34107858
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study.
Chen G; Su W; Yang J; Luo D; Xia P; Jia W; Li X; Wang C; Lang S; Meng Q; Zhang Y; Ke Y; Fan A; Yang S; Zheng Y; Fan X; Qiao J; Lian F; Wei L; Tong X
Front Med; 2020 Dec; 14(6):752-759. PubMed ID: 32926320
[TBL] [Abstract][Full Text] [Related]
3. Add-On Chinese Medicine for Coronavirus Disease 2019 (ACCORD): A Retrospective Cohort Study of Hospital Registries.
Shu Z; Chang K; Zhou Y; Peng C; Li X; Cai W; Wei L; Zheng Q; Tian H; Xia J; Yang K; Wang N; Liu J; Min X; Yan D; Sun J; Wu H; Li X; Zheng Y; Yu Z; Lu X; Yang Y; Jia T; Ji J; Zou Q; Wang Y; Xiao M; Zhang Q; Xiong Y; Sun F; Zhu Q; Jiang X; Wang G; Tang SC; Zhang J; Li X; Zhang N; Zhang B; Tong X; Liu B; Zhou X; Chan KW; Li X
Am J Chin Med; 2021; 49(3):543-575. PubMed ID: 33683189
[TBL] [Abstract][Full Text] [Related]
4. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study.
Zhang L; Zheng X; Bai X; Wang Q; Chen B; Wang H; Lu J; Hu S; Zhang X; Zhang H; Liu J; Shi Y; Zhou Z; Gan L; Li X; Li J
Phytomedicine; 2021 May; 85():153531. PubMed ID: 33799224
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
[TBL] [Abstract][Full Text] [Related]
6. Effect and safety of Chinese herbal medicine granules in patients with severe coronavirus disease 2019 in Wuhan, China: a retrospective, single-center study with propensity score matching.
Wang Y; Liu Y; Lv Q; Zheng D; Zhou L; Ouyang W; Ding B; Zou X; Yan F; Liu B; Chen J; Liu T; Fu C; Fang Q; Wang Y; Li F; Chen A; Lundborg CS; Guo J; Wen Z; Zhang Z
Phytomedicine; 2021 May; 85():153404. PubMed ID: 33637412
[TBL] [Abstract][Full Text] [Related]
7. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.
Tian J; Yan S; Wang H; Zhang Y; Zheng Y; Wu H; Li X; Gao Z; Ai Y; Gou X; Zhang L; He L; Lian F; Liu B; Tong X
Pharmacol Res; 2020 Nov; 161():105127. PubMed ID: 32791263
[TBL] [Abstract][Full Text] [Related]
8. Treatments Associated with Lower Mortality among Critically Ill COVID-19 Patients: A Retrospective Cohort Study.
Zhao X; Gao C; Dai F; Treggiari MM; Deshpande R; Meng L
Anesthesiology; 2021 Dec; 135(6):1076-1090. PubMed ID: 34597362
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
Shu Z; Zhou Y; Chang K; Liu J; Min X; Zhang Q; Sun J; Xiong Y; Zou Q; Zheng Q; Ji J; Poon J; Liu B; Zhou X; Li X
Front Med; 2020 Dec; 14(6):760-775. PubMed ID: 32926319
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effect of Traditional Chinese Medicine Shenhuang Granule in Critically Ill Patients with COVID-19: A Single-Centered, Retrospective, Observational Study.
Feng J; Fang B; Zhou D; Wang J; Zou D; Yu G; Fen Y; Peng D; Hu J; Zhan D
J Microbiol Biotechnol; 2021 Mar; 31(3):380-386. PubMed ID: 33746189
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study.
Wang Y; Yan X; Huang C; Sun Y; Yao C; Lin Y; Xiao W
Curr Med Res Opin; 2021 Jan; 37(1):13-19. PubMed ID: 33210547
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
13. Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021.
Zhang Y; Liu Y; Li M; Feng S; Li X; Gao Z; Yang Y; Tong X
Pharmacol Res; 2022 Apr; 178():106174. PubMed ID: 35288309
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
15. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
Zhang K; Tian M; Zeng Y; Wang L; Luo S; Xia W; Zhang X; Zha Y
Complement Ther Med; 2020 Aug; 52():102473. PubMed ID: 32951723
[TBL] [Abstract][Full Text] [Related]
16. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B
Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study.
Zhang HT; Huang MX; Liu X; Zheng XC; Li XH; Chen GQ; Xia JY; Hong ZS
Am J Chin Med; 2020; 48(4):779-792. PubMed ID: 32420751
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial.
Zhou S; Feng J; Xie Q; Huang T; Xu X; Zhou D; Zhang W; Sun S; Liu X; Wu X; Che J; Fan T; Zou D; Wang J; Zhan D; Peng D; Feng Y; Yu G; Yuan Z; Fang B
Phytomedicine; 2021 Aug; 89():153612. PubMed ID: 34126419
[TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study.
Al Sulaiman K; Aljuhani O; Saleh KB; Badreldin HA; Al Harthi A; Alenazi M; Alharbi A; Algarni R; Al Harbi S; Alhammad AM; Vishwakarma R; Aldekhyl S
Sci Rep; 2021 Sep; 11(1):17648. PubMed ID: 34480041
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
